Yuval Avni

LifeBond Ltd. engages in the development of medical devices designed to restore and repair tissues to reduce post-operative complications. The company was founded by Nir Mashkif, Orahn Preiss-Bloom and Ishay Attar in 2007 and is headquartered in Caesarea, Israel.

Giza Venture Capital (Giza Venture) is a venture capital firm founded in 1992 by Zeev Holtzman and Zvi Schechter. The firm is headquartered in Tel Aviv, Israel.

Samsara Vision, Inc. engages in the business of research, development, manufacturing, and marketing proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. It operates under the United States and Other geographical segments. The company was founded by Isaac Lipshitz, David Lifschitz, Yossi Gross, Boaz Lifschitz, and Eyal Lifschitz in 1997 and is headquartered in Far Hills, NJ.

Navotek Medical Ltd. operates as a medical device company which develops a system that will enable the precise location of tumors. It offers RealEye, a fiducial-based patient positioning and real-time target monitoring system for radiation therapy; and Tracer, an implantable fiducial that is used for marking target tissue and enabling localization based on its radioactive signal. The company also develops RealEye Motion, an advanced software application add-on to the RealEye system that is designed to enable the monitoring and tracking of moving organs paths throughout the radiation therapy. Navotek Medical was founded by Shimon Eckhouse, Shlomi Ben-Ari, Giora Kornblau and David Maier Neustadter in 2005 and is headquartered in Yokneam, Israel.

Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.

Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel.

Swanlaab Venture Factory SGEIC SA (Swanlaab Venture Factory) is an Independent Venture Capital firm founded in 2014. It is headquartered in Alcobendas, Spain.

Crescendo Venture Partners (Crescendo Venture) is a venture capital firm founded in 2018. The firm is headquartered in Tel-Aviv, Israel.